HMOX1 and neoplasm: These nanoparticles exploit the high ROS gradient in the glioma microenvironment to trigger the selective binding of Au(I) to overexpressed TrxR, activating HMOX1-regulated noncanonical ferroptosis in glioma cells and leading to tumor suppression (Zhang Xiaoqian et al., 2023).